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Abstract
Gastrectomy (Gsx) is associated with altered emotional function and a predisposition to depression⁄anxiety disorders. Here we
investigated the effects of Gsx on emotional reactivity in rats and explored the underlying neurobiological mechanisms. Gsx- and
sham-operated rats were exposed to behavioural tests that explore anxiety- and depression-like behaviour (open ﬁeld, black and
white box, elevated plus maze, social interaction, forced swim) as well as memory (object recognition). The potential neurobiological
mechanisms underlying these differences were explored by measuring (i) turnover of candidate neurotransmitter systems in the
nucleus accumbens, (ii) hippocampal neurogenesis by BrdU labelling or by analysis of candidate genes involved in neuronal growth
and (iii) changes in mRNA expression of candidate genes in dissected hippocampal and amygdala tissue. Data from individual
behavioural tests as well as from multivariate analysis revealed differing emotional reactivity between Gsx- and sham-operated rats.
Gsx rats showed reduced emotional reactivity in a new environment and decreased depression-like behaviour. Accumbal serotonin
and dopamine turnover were both reduced in Gsx rats. Gsx also led to a memory deﬁcit, although hippocampal neurogenesis was
unaffected. Of the many candidate genes studied by real-time RT-PCR, we highlight a Gsx-associated decrease in expression of
Egr-1, a transcription factor linked to neural plasticity and cognition, in the hippocampus and amygdala. Thus, Gsx induces an
alteration of emotional reactivity and a memory⁄cognitive deﬁcit that is associated with reduced turnover of serotonin and dopamine
in the nucleus accumbens and decreased expression of Egr-1 in the hippocampus and amygdala.
Introduction
As recently as 1999, gastric carcinoma was reported to be the second
largest cause of cancer death in the world (Liedman, 1999), although
its incidence has been continuously decreasing during the past decade.
Total gastrectomy (Gsx) is still a mainstay treatment for this cancer
and is needed in approximately 60% of cases. Following surgery, a
variety of symptoms and impairments emerge, collectively referred to
as the ‘postgastrectomy syndrome’ (Liedman, 1999). These include
reduced appetite, weight loss, osteopaenia and malnutrition. Loss of
reservoir function of the stomach, dysphagia, dyspepsia, altered
intestinal motility, malabsorption and so-called ‘gastric dumping
syndrome’ have been offered as explanations for the weight loss.
Gsx disrupts the endocrine milieu, including that of circulating
hormones regulating food intake and energy balance such as the
orexigenic and pro-obesity hormone ghrelin (Ariyasu et al., 2001;
Dornonville de la Cour et al., 2001) and also the anorexigenic
hormones cholecystokinin (CCK; Inoue et al., 1987) and leptin
(Furnes et al., 2008a). We have demonstrated beneﬁcial effects of
ghrelin replacement for Gsx-associated suppression of body weight
and body fat (Dornonville de la Cour et al., 2005) reﬂecting direct
hypothalamic effects on genes regulating energy balance (Egecioglu
et al., 2008). We were unable to explain Gsx-induced weight loss by
suppressed food intake or increased energy expenditure (Dornonville
de la Cour et al., 2005) although in a subsequent study in rats, we did
observe a reduction in cumulative food intake (Furnes et al., 2008a).
In addition to metabolic disturbance, patients who have undergone
Gsx for gastric cancer appear to be predisposed to depression⁄anxiety
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Wu et al., 2000; Fujita et al., 2003; Hjermstad et al., 2006). Given
the emerging neurobiology concerning the role of gut hormones
in psychiatric diseases such as anxiety disorders and depression
(Asakawa et al., 2001; Hernandez-Gomez et al., 2002; Kanehisa
et al., 2006; Lutter et al., 2008) as well as memory (Hebb et al., 2005;
McNay, 2007), together with the neurochemical overlap between
metabolic and psychiatric disease, it seems likely that the endocrine
stomach has a role in the emotionality changes that accompany Gsx.
Here we sought to determine whether Gsx rats differ from sham-
operated rats in terms of (i) their behavioural responses when
subjected to tests frequently used to evaluate anxiety, depression and
memory in rodents, (ii) their brain neurochemistry (turnover of
transmitter systems involved in emotional reactivity in relevant brain
regions), (iii) nerve cell regeneration (hippocampus) and (iv) the
expression patterns of genes involved in anxiety⁄depression, nerve
cell regeneration, plasticity and signal transduction in brain areas
implicated in the neuropathology of affective disorders (Campbell &
Macqueen, 2004; Mathew et al., 2008).
Methods
Animals and experimental procedures
Gsx or sham operation was performed on age-matched adult male
Sprague–Dawley rats (weighing approximately 155 g at the start of
the experiment, obtained from B&K Universal, Sollentuna, Sweden).
They were group-housed upon arrival and maintained in a 20  C, 40–
45% humidity and 12-h light⁄dark cycle with free access to standard
rat chow (Harlan Teklad, Norfolk, UK) and tap water. All surgical
procedures were performed in anaesthetized animals (60–75 mg⁄kg
Ketalar
  and 0.5 mg⁄kg Domitor
  i.p.; Pﬁzer, Sweden; Orion Co.,
Finland) through a short upper midline incision. Sham operation
consisted of laparotomy. Gsx was performed by removing the whole
stomach followed by joining the oesophagus and duodenum end-to-
end. Animals were allowed to recover from surgery for 3 weeks
before commencing the behavioural testing. All animal experiments
were approved by the local Ethics Committee in Gothenburg, Sweden.
Twenty rats were used in the study: 10 sham rats and 10 Gsx rats. Four
of the Gsx rats experienced post-operative complications resulting in
excessive weight loss and were killed prior to the behavioural testing
according to local Ethics Committee guidelines.
Behavioural testing for emotional reactivity and memory testing
Emotional reactivity was explored in behavioural tests designed to
explore anxiety-like behaviour (the open ﬁeld test, the black and white
box and the elevated plus maze; Ramos & Mormede, 1998; Cryan
et al., 2002) and depression-like behaviour (the forced swim test;
Porsolt et al., 1977). The object recognition test was used to assess
memory performance (Carlini et al., 2008).
To facilitate adaptation, Gsx and sham animals were placed in an
ante-room 1 h prior to all behavioural testing. The tests were carried
out during the light phase, between 08:30 and 11:30 h, using a
balanced design and in the order as listed below. Behaviour was
recorded via a camera directly linked to a computer located in an
adjacent room. All of the behavioural analyses were done by an
observer who was unaware of the individual surgical manipulation.
Open ﬁeld test
The open ﬁeld consisted of a wood box (60 · 60 · 60 cm
3). The
illumination at ﬂoor level was 700 lux. The open ﬁeld was divided
into a 25 · 25-cm central zone and a border zone surrounding it. To
evaluate locomotor activity, the ﬂoor was divided into 16 equal
squares. At the beginning of the test, rats (sham, n = 10; Gsx, n =6 )
were individually placed in the open ﬁeld and their behaviour was
analysed during the 10-min test period: time spent in the central zone,
the number of entries into the central zone, the number of groomings
and the time spent grooming, the number of rearings in the central and
peripheral zone and the number of line crossings. The ﬁeld was
cleaned between each test session.
Object recognition
The day after the open ﬁeld test, object recognition memory was
assessed using the object recognition task (sham, n = 9; Gsx, n = 5).
Trials consisted of a sample trial (T1) and a recognition trial (T2). The
two trials were separated by an inter-trial interval of 24 h. During T1,
rats were placed in the enclosure in the presence of two identical
objects for 3 min. Any animal not exploring (deﬁned as the animal
having its head within 2 cm of the object while looking at, snifﬁng or
touching it) the objects for 20 s within the 3-min period was not
included in the experiment.
During T2, the rats were again placed in the enclosure with a
previously presented familiar object together with a novel object for a
period of 3 min. Time spent exploring the familiar and novel objects
was recorded. The percentage of time spent exploring the new object
was calculated. Animals exploring the objects for < 10 s were
removed from the study. The objects used were a white wood
cylinder and a green wood pyramid. Two different sets of objects were
used to enable them to be wiped between one rat and the next, to
prevent the possibility of olfactory recognition.
Black and white box
The box was made of wood and divided in two compartments,
connected by an opening (5 · 5c m
2). The ﬁrst compartment (18 ·
27 · 27 cm
3) was painted black and covered by a black top giving an
illumination around 10 lux. The other compartment (27 · 27 ·
27 cm
3) was painted white and was lit by a white incandescent bulb
(100 lux). The ﬂoor of the box was cleaned before each trial. At the
beginning of each 10 min trial, the rat (sham, n = 10; Gsx, n = 6) was
placed in the centre of the white compartment facing the opening. The
behavioural parameters scored were: the latency until the ﬁrst entry
into the black compartment, the time spent in the white compartment,
the number of transitions between the black and the white compart-
ment, the number of rearings in both compartments, the number of
groomings and the time spent grooming.
Elevated-plus maze
The apparatus consisted of two open arms (50 · 10 cm
2) surrounded
by a 1-cm-high plexiglass and two closed arms (50 · 10 · 38 cm
3)
that emerge from a central platform. The apparatus was made from
dark grey PVC and the arms were elevated 73 cm above the ﬂoor.
A white incandescent bulb provided a light intensity of 100 lux over
the open arms and of 20 lux over the closed arms. At the beginning of
each trial, the rat (sham, n = 10; Gsx, n = 6) was placed on the central
platform facing a closed arm. The ﬂoor of the maze was cleaned
before each trial. The rat behaviour was videotaped over 5 min and a
trained observer scored the parameters from the videotape. The
behavioural parameters scored were: the number of entries into the
closed arms and in all arms, the number of open arm entries (expressed
as a percentage of the total number of entries; an entry was counted
when both forepaws were placed on the respective arm), the time spent
there (expressed as a percentage of the total time spent in all arms), the
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central platform.
Forced-swim test
The procedure was a modiﬁcation of that described by Porsolt et al.
(1977). Animals (sham, n = 10; Gsx, n = 6) were placed in an
individual glass cylinder (diameter 17 cm, height 40 cm) containing
water (height 24 cm, 22  C). Two sessions were conducted (an initial
15-min pre-test and, on the next day, a 5-min test). The duration of
immobility, struggling and swimming (in seconds) were manually
measured during each 5-min period of the pre-test sessions and during
the 5 min of the test sessions by an experimenter who was unaware of
the surgical groups. Immobility was deﬁned as the minimal movement
necessary for the rat to stay aﬂoat. Floating occurred when rats
remained immobile with only occasional slight movements to keep the
body balance and the nose above the water. Immobility was assigned
when no additional activity was observed other than that necessary to
keep the rat’s head above the water. Swimming occurred when rats
moved all four limbs, swimming around in the tank or diving.
Struggling was recorded when rats moved strongly all four limbs with
the front paws breaking the water surface or scratching the glass
cylinder wall.
Dissection, blood collection and corticosterone measurement
Eight weeks following surgery and 2 weeks following the last
behavioural experiment, body weight was recorded and the rats were
killed by decapitation. Blood was collected from the trunk into EDTA-
containing tubes immediately after decapitation and plasma was
prepared. The adrenal glands and the thymus were dissected and
weighed, as such organs typically have reduced weight in chronic
stress paradigms that lead to depression. Brains were removed and
dissected regions (hippocampus, amygdala, nucleus accumbens and
prefrontal cortex) were frozen in liquid nitrogen and stored at )80  C.
Plasma corticosterone, also an indicator of chronic stress, was
measured in plasma using a radioimmunoassay kit (MP Biomedical,
Orangeburg, NY, USA) with
125I-corticosterone as standard.
Content of monoamines and metabolites
The nucleus accumbens and prefrontal cortex were homogenized
using a Soniﬁer B30 (Branson Sonic Power Co., Danbury, CT, USA)
in 0.1 m HClO4 containing Na2EDTA (2.5 mm). After centrifugation
(10 000 g,4 C, 10 min), the supernatant was immediately analysed
for dopamine (DA), serotonin (5-HT), dihydroxyphenylacetic acid
(DOPAC), 5 hydroxyindolacetic acid (5-HIAA) and homovanillic acid
(HVA) using a split fraction HPLC – electrochemical detection
system. DA and 5-HT were separated on an ion-exchange column
(Nucleosil, 5 l SA 100 A, 150 · 2 mm; Phenomenex, Torrance, CA,
USA) with a mobile phase consisting of 0.049 m citric acid, 0.0114 m
NaOH and 0.012 mm Na2 EDTA. Ten sham rats and six Gsx rats were
evaluated.
Quantiﬁcation of candidate genes in hippocampus and
amygdala
Total RNA was individually prepared from the hippocampus and
amygdala using an RNeasy Mini Lipid tissue kit (Qiagen, Hilden,
Germany) with additional DNAse treatment (Qiagen). Isolated RNA
was diluted in nuclease-free water (Ambion), and RNA concentrations
were determined using a spectrophotometer. RNA integrity was
ensured using the RNA 6000 Nano kit and an Agilent 2100
Bioanalyzer (Agilent Technologies).
For cDNA synthesis, total RNA corresponding to 1 lg was
reversed transcribed in a total volume of 20 lL, using random
hexamers (Applied Biosystems, Sundbyberg, Sweden) and Superscript
III reverse transcriptase (Invitrogen Life Technologies, Paisley, UK),
according to the manufacturer’s description. Recombinant RNaseout
 
Recombinant Ribonuclease Inhibitor (Invitrogen) was added to
prevent RNase-mediated degradation. All the cDNA reactions were
run in triplicate.
TaqMan
  Custom Array platforms were designed with TaqMan
probe and primer sets for target genes chosen from an on-line
catalogue (Applied Biosystems). The sets were factory-loaded into the
384 wells of TaqMan
  Arrays. Reactions consisting of 2 lL cDNA (to
a ﬁnal concentration of 100 ng starting RNA) combined with 48 lL
nuclease-free water and 50 lLTaqMan
  Gene Expression Master Mix
(Applied Biosystems) were loaded to each port. Duplicates of cDNA
were run on separate LDA cards and analysed using the 7900HT
system with a TaqMan LDA Upgrade (Applied Biosystems). Thermal
cycling conditions were: 50  C for 2 min, 94.5  C for 10 min, 97  C
for 30 s and 59.7  C for 1 min.
To calculate the expression stability of ﬁve reference genes
[ribosomal protein L27, 18S rRNA, b-actin, glyceraldehyde-3-phos-
phate dehydrogenase (GAPDH) and Cyclophilin A] the NormFinder
algorithm (http://www.mdl.dk/publicationsnormﬁnder.htm) was used.
Gene expression values were calculated based on the DDCt method
(Livak & Schmittgen, 2001), where the saline-treated group was
designated the calibrator. Brieﬂy, DCt represents the threshold cycle
(Ct) of the target minus that of the reference gene and DDCt represents
the DCt of each target minus that of the calibrator. Relative quantities
(RQ) or fold changes were determined using the equation: relative
quantity = 2DDCt. For the calibrator sample, the equation is relative
quantity = 2
)0, which is 1; therefore, every other sample is expressed
relative to this.
Target genes included transcription and neural growth factors as
well as genes involved in receptor and transporter activity. All
TaqMan assay identities are listed in Table 1.
Hippocampal neurogenesis
Treatment with BrdU through once daily intraperitoneal injections
started 3 days following the surgical procedure and continued for 17
consecutive days. BrdU (Sigma, St. Louis, MO, USA) was dissolved
in 0.9% NaCl at a concentration of 10 mg⁄mL and given at
50 lg⁄kg⁄day. Eight weeks following surgery animals were perfused
transcardially with 4% paraformaldehyde in phosphate buffer. Brains
were removed, stored in ﬁxative overnight, transferred into 30%
sucrose and frozen at )80  C. The left hemisphere was cut in sagittal
sections at 40 lm on a sliding microtome (Leica SM2000R; Leica
Microsystems, Nussloch, Germany). Serial sections were collected
and stored in tissue cryoprotection solution (TCS: 25% glycerine, 25%
ethylene glycol and 50% 0.1 n phosphate buffer) until subsequent
processing for immunocytochemistry.
From each animal, every 12th section was selected for immuno-
ﬂuorescence staining for BrdU, Neu-N and Prox-1. The sections were
rinsed using Tris-buffered saline (TBS) for 3 · 10 min, pre-treated in
2 m HCl at 37  C for 30 min to denaturate DNA and rinsed in 0.1 m
borate buffer (pH 8.5) for 10 min at room temperature. After pre-
treatment and blocking in 3% normal donkey serum (Jackson
ImmunoReasearch Laboratories Inc., Suffolk, UK) and 0.1% Triton
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mixture containing antibodies against BrdU (1 : 250 Rt anti-BrdU;
Nordic Biosite AB, Sweden), NeuN (1 : 100 Ms anti-NeuN; Chem-
icon International, USA) and Prox-1 (1 : 1000 Rb anti-Prox1;
Chemicon) at 5  C overnight. Following incubation with primary
antibody the sections were rinsed with TBS and incubated in the dark
for 2 h at room temperature with secondary antibodies (Dk anti-Rt IgG
488 for BrdU detection, Dk anti-Ms IgG 647 for NeuN detection and
Dk anti-Rb IgG 555 for detection of Prox1; Molecular Probes Inc.,
USA), all at dilutions of 1 : 1000. Sections were mounted onto Super
Frost Microscope slides, coverslipped with ProLong Gold antifade
reagent containing DAPI (4¢,6-diamidino-2-phenylindole) and ﬁnally
stored in the dark to prevent ﬂuorescence fading.
Cell counting comprised counting the BrdU-labelled cells seen with
the N3 ﬁlter cube in a stereo microscope (Leica DM 6000 B). Prox-1
staining in the green channel was used to better visualize the dentate
gyrus. To determine the number of neural precursor cells that matured
into neurons, 50 BrdU-positive cells per animal were randomly
analysed for NeuN staining, giving a ratio of the amount of
NeuN⁄BrdU-positive double-labelled cells. Phenotyping of Brdu⁄
BrdU-NeuN double labelled cells was performed with a confocal
microscope (Leica DM IRE2) by non-sequential scanning combined
with z-scanning. The analysis was done on 50 cells per animal in
which the BrdU was visualized with the 488-nm laser line and the
NeuN using the 647-nm laser line.
Statistical analysis
Data are expressed as means ± SEM. Data obtained were analysed
either by a Student’s t-test or by a Mann–Whitney U-tests when data
were not normally distributed or were of unequal variance. The results
of the forced swim test obtain during the second day were compared
with those obtained on the ﬁrst day using a two-way anova
(time · surgery) followed by a HSD Tukey post hoc test for
comparisons between groups when appropriate. In each case,
P < 0.05 was considered statistically signiﬁcant.
A discriminant analysis was performed for each test (except for the
object recognition) to test the accuracy of divergence in emotional
reactivity between the two surgical groups. Different parameters given
by this analysis were reported: a classiﬁcation matrix was used to
determine to which groups (sham vs. Gsx groups) each animal tested
most likely belonged (results expressed as a percentage), the
discriminating power of each variable was given by the F-values
(indicating its statistical signiﬁcance in the discrimination between
groups), and the tolerance value was a measure of the redundancy for
a variable with all previous variables included in the model. When a
variable was highly redundant, its tolerance value and its contribution
to the model were low.
In addition, to dissect the speciﬁc emotional dimensions in each
surgical group, a principal components analysis was performed using
parameters obtained in the different tests: the open ﬁeld test (number
of rearings in the periphery, number of line crossings, number of
groomings), the black⁄white box (number of rearings in the white
compartment, number of groomings), the elevated plus-maze (number
of rearings in the closed arms, percentage of time spent in the open
arms, percentage of time spent in the central platform) and the forced
swim test (time swimming during the ﬁrst triad, time spent struggling
during the second triad, time spent swimming the second day). These
variables have been chosen to avoid keeping variables with a
correlation > 0.9. An orthogonal rotation (varimax) of the factor
matrix was used to analyse the data, ensuring that the extracted factors
were independent of each other. Considering the sample size, a
Spearman correlation matrix, which is less sensitive for single outliers,
was used (Gorsuch et al., 1998). An orthogonal rotation (varimax) of
the factor matrix was used to analyse the data, which ensured that the
extracted factors were independent. Only factors with eigenvalues
> 0.4 were kept for analysis.
Results
Body weight, organ weight and hormone measurements
Body weight before surgery was not different (sham group, 156 ± 1 g;
Gsxgroup,154 ± 2 g;t12 = 1.26,P = 0.23).At8 weeksaftersurgery(at
the endoftheexperiment),the Gsxratshad alowerbody weightthan the
sham group (294 ± 18 and 508 ± 14 g, respectively, t12 =9 . 6 5 ,
P = 0.00001). In the Gsx group, absolute weights of the thymus and
adrenal glands were reduced and tended to be reduced, respectively
(thymus: sham group, 1.73 ± 0.05 mg; Gsx group, 1.4 ± 0.03 mg,
t10 =5 . 5 7 ,P = 0.00024; adrenal: sham group, 0.961 ± 0.005 mg; Gsx
group, 0.946 ± 0.004 mg, t12 =2 . 9 1 , P = 0.012; data not shown).
However, when adjusted for body weight, the weights of these organs
were increased (thymus: sham group, 0.26 ± 0.01 mg; Gsx group,
Table 1. Gene targets and TaqMan assay identities (id) loaded on the
Taq
 Man Array
Gene target Gene name Assay id
Endogenous controls
18S Eukaryotic 18S rRNA Hs99999901_s1
Actb Actin, beta Rn00667869_m1
Gapdh Glyceraldehyde-3-phosphate dehydrogenase Rn99999916_s1
Ppia Peptidylprolyl isomerase A Rn00690933_m1
Rplp2 Ribosomal protein, large P27 Rn01479927_g1
Transcriptor factor ⁄ signal transduction
Crebbp CREB binding protein Rn00591291_m1
Egr1 Early growth response 1 Rn00561138_m1
Map2k2 Mitogen activated protein kinase kinase 2 Rn00590971_m1
Trh Thyrotropin-releasing hormone Rn00564880_m1
Transporter ⁄ enzymatic activity
Gad1 Glutamic acid decarboxylase 1 (67) Rn00566593_m1
Th Tyrosine hydroxylase Rn00562500_m1
Slc1a2 Glt1 solute carrier family 1 (glial high afﬁnity
glutamate transporter), member 2
Rn00568080_m1
Slc6a3 Dat1 solute carrier family 6 (neurotransmitter
transporter, dopamine), member 3
Rn00562224_m1
Slc6a4 5HTT neurotransmitter transporter, serotonin Rn00564737_m1
Neural growth ⁄ differentiation
Bdnf Brain-derived neurotrophic factor Rn01484928_m1
Ntrk2 Neurotrophic tyrosine kinase, receptor, type 2 Rn00820626_m1
Ncam1 Neural cell adhesion molecule 1 Rn00580526_m1
Ngfb Nerve growth factor beta Rn01533872_m1
Receptor activity
Adipor1 Adiponectin receptor 1 Rn01114954_g1
Cckbr Cannabinoid receptor1 Rn00565867_m1
Drd3 Dopamine receptor 3 Rn00567568_m1
Gabra1 Gamma-aminobutyric acid A receptor, alpha1 Rn00788315_m1
Gabra3 Gamma-aminobutyric acid A receptor, alpha3 Rn00567055_m1
Gabra4 Gamma-aminobutyric acid A receptor, alpha4 Rn00589846_m1
Gabra5 Gamma-aminobutyric acid A receptor, alpha5 Rn00568803_m1
Galr2 Galanin receptor 2 Rn01773918_m1
Galr3 Galanin receptor 3 Rn02132531_s1
Ghsr Growth hormone secretagogue receptor Rn00821417_m1
Htr1a 5-hydroxytryptamine (serotonin) receptor 1A Rn00561409_s1
Htr2c 5-hydroxytryptamine (serotonin) receptor 2C Rn00562748_m1
Insr Insulin receptor Rn00567070_m1
Lepr Leptin receptor Rn01433205_m1
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0.19 ± 0.01 mg; Gsx group, 0.33 ± 0.02 mg, t12 = )7.93 P=
0.000004; data not shown). Plasma corticosterone levels were reduced
by Gsx (sham group, 393 ± 38 ng⁄mL; Gsx group, 116 ± 37 ng⁄mL,
t12 =5 . 5 9 ,P = 0.00016).
Behavioural studies of anxiety in sham-operated and Gsx rats
There are indications from individual behavioural tests of anxiety-like
behaviour that emotional reactivity differs between sham-operated and
Gsx rats. In the open ﬁeld test, the number of peripheral rearings and the
number of line crossings were lower in Gsx rats than in sham-operated
rats (t14 =2 . 6 7 ,P=0.018 and t14 = 2.938, P = 0.01). The ﬁnal number
of surviving operated rats in the two experimental groups was relatively
low for a behavioural study (i.e. six Gsx and ten sham-operated), yet it
seems clear that the two experimental groups had an different overall
emotional response (Fig. 1). No signiﬁcant difference was observed
regarding the time spent grooming (U =1 6 ,P=0.13), the number of
centralrearings(U =2 2 . 5 ,P=0.41),thenumberofentriesinthecentral
area (t14 = )0.63, P=0.6) and the time spent in the central area
(t14 = )0.03, P=0.97). In this test, the number of groomings tended to
be lower in the Gsx group although this did not reach statistical
signiﬁcance (t14 = 1.9, P=0.07). In the black and white box (Table 2)
the number of groomings also tended to be lower in the Gsx group
(U =1 4 ,P=0.08) but otherwise there was no signiﬁcant difference
between the Gsx and sham groups for any of the other parameters
measured (time spent grooming, U =1 6 ,P = 0.13; latency until the ﬁrst
entry into the black compartment, t14 = 0.01, P = 0.99; time spent in the
white compartment, t14 =0 . 6 9 , P = 0.49; number of transitions,
t14 =1 . 0 9 , P = 0.29; number of rearings in the white and black
compartment, t14 =0 . 8 9 ,P =0 . 3 8a n dt14 =0 . 5 4 ,P = 0.59, respec-
tively). Similarly, in the elevated plus maze (Table 2) there was no
difference between groups for any parameter measured (number of
closed arm entries, t14 = )0.49, P = 0.63; number of total arm entries,
t14 = )0.12, P = 0.9; percentage of open arm entries, t14 = 0.34,
P = 0.73;percentage of timespentinopenarms, t14 = )1.56,P = 0.14).
Behavioural studies of depression in sham-operated and Gsx
rats – forced swim test
In the forced swim test a decrease in immobility and an increase in
active movements is indicative of a decrease in depression-like
behaviour (Porsolt et al., 1977). On the ﬁrst day of the forced swim
test, behavioural measurements were made in sequential 5-min triads
(Fig. 2A and B) and on the second day they were made over one
5-min period only (Fig. 2C). On the ﬁrst day, during the ﬁrst triad, the
Gsx group spent less time immobile (U =5 ,P = 0.0066) and more
time struggling (t14 = )2.22, P = 0.43). During the second triad, time
spent immobile was lower in the Gsx group, whereas the time spent
swimming was increased (t14 = 3.46, P = 0.0038 and t14 = )2.99,
P = 0.0095). In the third triad, the data were similar to the second triad
but with only a tendency towards signiﬁcance (t14 = 2.06, P = 0.058
and t14 = )2.07, P = 0.057). During the entire 15 min of exposure,
Gsx rats displayed a decrease in the amount of time spent immobile
(t14 = 3.44, P = 0.0039) while they increased both the time spent
swimming (t14 = )2.85, P = 0.012) and the time struggling
(t14 = )2.6, P = 0.02, Fig. 2B).
anova revealed an interaction between day and surgical group
(F1,14 = 8.05, P<0.05). On the second day, Gsx rats spent less time
immobile and more time swimming in comparison with sham-
operated rats (both P<0.001, Fig. 2C). When comparing the 2 days,
the sham-operated rats spent more time immobile on the second day
(P<0.001) and there was a similar trend for the Gsx rats (P=0.07).
For both surgical groups the time spent struggling was lower on the
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Fig. 1. Behavioural parameters of sham-operated (n = 10) and Gsx rats (n = 6) in the open ﬁeld during the 10-min test period. Columns and bars represent
mean ± SEM. *P<0.05.
Table 2. Behavioural parameters of sham-operated (n = 10) and Gsx rats
(n = 6) in the black and white box and elevated plus maze
Sham Gastrectomy
Black and white box
Number of groomings 2.6 ± 0.3 1.7 ± 0.2
Time grooming (s) 31.0 ± 6.2 16.7 ± 1.9
Latency ﬁrst white entry (s) 2.6 ± 1.7 2.5 ± 0.9
Time in white (s) 23.5 ± 7.9 15.9 ± 5.2
Transition number 3.2 ± 0.8 2.0 ± 0.4
Rearing number in white 2.9 ± 1.1 1.5 ± 0.8
Rearing number in black 14.7 ± 1.7 13.2 ± 2.3
Elevated plus maze
Closed arm entries 4.9 ± 0.8 5.5 ± 0.8
Total arm entries 8.2 ± 1.0 6.0 ± 1.1
Percentage open arm entries 34.1 ± 4.5 24.3 ± 2.8
Percentage time spent open arm 10.1 ± 2.8 8.7 ± 2.8
Percentage time spent central platform 3.6 ± 1.3 7.0 ± 1.8
The test periods were 10 min in the black and white box and 5 min in the
elevated plus maze. Values are expressed as mean ± SEM.
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studied the Gsx rats tended to spend more time struggling compared
with the sham-operated rats (P<0.05). Finally, anova revealed an
interaction between day and surgery (F1,14 = 8.28, P<0.05). In
addition, in comparison with the ﬁrst day, sham-operated rats spent
less time swimming on the second day (P < 0.05) whereas Gsx rats
did not modify their swimming behaviour between the ﬁrst and the
second day (P=0.67).
Discriminant and multivariate analysis of the behavioural tests
A discriminant analysis was performed to test the accuracy of
divergence between the two surgical groups (Table 3). The percentage
correct discrimination as well as the discriminating factors between the
groups are given, together with their corresponding F and P values and
tolerance values. Gsx- and sham-operated and rats were markedly
divergent with a high percentage of discrimination in all tests used. For
the different anxiety tests, the most important parameters that
discriminated Gsx- and sham-operated rats were: the number of line
crossings in the open ﬁeld test, the number of rearings in the white
compartment in the black and white box, the percentage of time spent
on the central platform and the percentage of open arm entries in the
elevated plus maze. In the forced swim test, the most important
distinguishing parameters were the time spent immobile during the ﬁrst
triad on the ﬁrst day and the time spent swimming on the second day.
To determine the main factor(s) that discriminate sham-operated and
Gsx rats, a principal components (multivariate) analysis based on the
mean values of each group was performed for variables of the
behavioural tests (Table 4). With the component analysis the 11
variables could be associated in four principal components with
eigenvalues higher than 1 and representing 76.4% of the total
variability. As the different factors were orthogonal to each other, it
was generally assumed that they reﬂected distinct biological phenom-
ena. To facilitate interpretation of the data, we present only the most
signiﬁcant loadings (higher than 0.4) in Table 4. The ﬁrst factor
represented 27.25% of the total variance. The parameters that
correlated with this factor were: (i) in the open ﬁeld, the number of
rearings in the peripheral area and the number of line crossings; (ii) in
the black and⁄white box, the number of rearings in the white
compartment; and (iii) in the elevated plus maze, the percentage of
open arm entries. The second factor represented 20.82% of the total
variance. The parameters that loaded highly on this factor were: (i) in
the black and white box, the number of groomings; (ii) in the elevated
plus maze, the percentage of time spent on the central platform; and
(iii) in the forced swim test, the time spent immobile during the ﬁrst
triad on the ﬁrst day and the time spent swimming on the second day.
The third factor represented 16.29% of the total variance. The
parameters loading with this factor was derived mainly from the black
and white box, i.e. the number of rearings in the white compartment
and the number of groomings, but also the number of rearings in the
closed arm of the elevated plus maze. The last factor represented
Sham Gsx
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Fig. 2. Behavioural parameters of sham-operated (n = 10) and Gsx rats
(n = 6) in the forced swim test during (A) the three triads of the ﬁrst day, (B)
the 15 min of the ﬁrst day and (C) the ﬁrst 5 min of the 15 min pre-test session
at the ﬁrst day and during the test phase (5 min) on the second day. *P<0.05,
***P < 0.001 Gsx vs. sham;
¤P < 0.05,
¤¤¤P<0.001 when comparing day 1
and 2 for each surgical group.
Table 3. Results from the discriminant analysis of sham-operated and Gsx rats in the four behavioural tests
Test
Percentage correct
Discriminating variables FP Tolerance Sham Gsx
Open ﬁeld 100 83.3 Line crossings 5.44 0.03 0.99
Time grooming 0.66 0.23 0.99
Black and white box 80.0 83.3 Rearing white 4.39 0.05 0.58
Grooming time 1.11 0.31 0.32
Grooming latency 1.10 0.31 0.39
Grooming number 0.42 0.42 0.39
Elevated plus maze 90.0 83.3 Percentage time centre 6.78 0.02 0.60
Percentage entries open arm 4.95 0.04 0.60
Forced swim test
1st day 90.0 100 Immobility (1st triad) 11.11 0.01 0.55
Struggling (2nd triad) 2.57 0.13 0.58
Struggling (3rd triad) 0.62 0.44 0.91
Struggling (total) 0.02 0.87 0.57
2nd day 100 83.3 Swimming 24.78 0.00 0.99
Struggling 1.21 0.29 0.99
For each test the percentage of correct classiﬁcation of sham ⁄ Gsx animals is given. Within each test, variables were organized with the highest discriminating power
ﬁrst, as indicated by the F-value. The corresponding P-level was given for each F. The tolerance value is a measure of the redundancy of a variable with other
variables in the same test (a higher tolerance indicates lower redundancy).
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factor were: (i) in the open ﬁeld, the number of line crossings and the
number of groomings; (ii) in the elevated plus maze, the percentage of
time spent on the central platform; and (iii) in the forced swim test, the
time spent struggling during the second triad of the ﬁrst day. The
position of each individual animal of the two groups in relation to the
ﬁrst and the second factors is illustrated in Fig. 3.
Memory effects of Gsx
One rat from each surgical group was excluded from the experimental
protocol as they did not reach the cut-off of 20 s for the initial object
exploration. During the recognition trial, rats from the sham group
spent more time exploring the new object (t12 = 0.24, P = 0.81,
Fig. 4) whereas rats from the Gsx spent an equal amount of time
exploring the old and new object (t12 = 4.47, P = 0.0004, Fig. 4).
Consequently, the percentage of time spent exploring the new object
was higher in the sham group (t12 = 2.26, P = 0.043).
Content of monoamine and metabolites
In the prefrontal cortex there was no signiﬁcant difference in the
monoamines and metabolites measured between the sham-operated
and Gsx rats (Table 5). In the nucleus accumbens, both the turnover of
serotonin (5-HIAA⁄5-HT, t11 = 2.26, P = 0.044) as well as dopamine
(DOPAC⁄DA, U =6 ,P = 0.02, U-test) were decreased in the Gsx rats
(Table 5).
Relative mRNA expression changes in amygdala and
hippocampus
To study the effect of Gsx on gene expression in brain structures
involved in emotion and cognition (hippocampus and amygdala) we
studied mRNA expression of genes implicated in these processes. A
full list of the genes studied, including nomenclature⁄abbreviations, is
given in Table 1. In the hippocampus the following genes were down-
regulated in the Gsx rats when compared with the sham group:
Adipor1 (adiponectin receptor 1, RQ = 0.84, P=0.017), Insr (insulin
receptor, RQ = 0.82, P=0.013), Egr-1 (early growth response 1,
RQ = 0.74, P=0.015) and Trh (thyrotropin releasing hormone,
RQ = 0.76, P=0.021; Fig. 5A–D). The galanin receptor 3 (Gal 3)
was upregulated (RQ = 1.87, P=0.023) in the hippocampus of Gsx
rats (Fig. 5E). In the amygdala one gene was downregulated, namely
Egr-1 (RQ = 0.89, P=0.035). None of the genes studied in neural
growth⁄differentiation were different between the groups, namely
BDNF (brain-derived neurotrophic factor), Ntrk2 (neurotrophic tyro-
sine kinase receptor 2), Ncam1 (neural cell adhesion molecule 1) and
Ngfb (nerve growth factor beta) in any of the two structures (data not
shown). The genes selected to investigate changes in the serotonin
system (Htr1a, Htr2c and Sl6a4), the dopaminergic system (Ddr3, Th
and Sl6a3) and the GABAergic system (Gabar1, Gabar3, Gabar4,
Gabar5 and Gad1) were not changed after Gsx in either of the brain
structures studied (data not shown).
Table 4. Principal components (multivariate) analysis of 11 variables
obtained from the open ﬁeld, black and white box, elevated plus maze and
forced swim tests
Test ⁄ variable Factor 1 Factor 2 Factor 3 Factor 4
Open ﬁeld
Rearing number periphery 0.85
Line crossings 0.81 0.41
Grooming number 0.69
Black and white box
Rearing number white 0.40 0.73
Grooming number 0.54 0.54
Elevated plus maze
Rearing number closed arm 0.83
Percentage entries open arm 0.46
Percentage time centre )0.61 )0.59
Forced swim test
Immobility 1st triad 0.89
Struggling 2nd triad 0.81
Time swimming 2nd day )0.88
Percentage total variance 27.25 20.82 16.29 12.23
The most signiﬁcant factor loadings, higher than 0.4, are shown for each
behavioural parameter.
Factor 1
Factor 2
Sham
Gsx
Fig. 3. Distribution of sham-operated ⁄ Gsx rats along the two ﬁrst factors
extracted with the principal components analysis. Factor 1 was represented by
the horizontal axis and accounts for 27.25% of the total variance. Factor 2 was
represented by the vertical axis and accounts for 20.82% of the total variance.
This principal components analysis was based on the behavioural results
obtained in the open ﬁeld (number of rearings at the periphery, number of line
crossings, number of groomings), the black and white box (number of rearings
in the white compartment, number of groomings), the elevated plus maze
(number of rearings in the closed arms, percentage of entries into the open
arms, percentage of time spent in the central zone) and in the forced swim test
(immobility during the ﬁrst triad, struggling during the second triad, time spent
swimming the second day).
Time spent exploring (s)
0
4
8
12
Sham Gsx 
Old object
New object
* * * 
Fig. 4. Time spent exploring during the recognition trial of the object
recognition test. Rats from the sham group spent more time exploring the new
object whereas rats from the Gsx gruop spent the same time exploring the old
and new object. Sham, n = 9; Gsx group, n = 5. ***P < 0.001.
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The number of surviving neural precursor cells in the dentate gyrus
was not signiﬁcantly different between sham-operated and Gsx rats
(t12 = 0.24, P = 0.81) as detected by BrdU immunohistochemistry.
The ratio of neuronal precursor cells maturing into neurons, reﬂected
by ratio of the amount of NeuN⁄BrdU-positive double-labelled cells,
was decreased in Gsx rats compared with sham-operated rats (70.0 vs.
82.5%, respectively, t12 = 2.84, P = 0.015). However, when this ratio
was multiplied by the total number of BrdU-positive cells acquired by
stereology, this difference was lost (t12 = 1.02, P = 0.326).
Discussion
Gastrectomy alters emotional reactivity in rats
Inspired by the clinical observation that Gsx patients have an altered
emotional function and predisposition to depression⁄anxiety disor-
ders, we demonstrate that Gsx rats differ from sham-operated rats in
their emotional reactivity using tests that assess anxiety- and
depression-like behaviour in rodents. To facilitate the interpretation
of the large body of data (variables) emerging from these tests we used
a powerful principal components (multivariate) analysis that enabled
the identiﬁcation of four ‘factors’ that account for most (around 77%)
of the variance in emotional reactivity between the Gsx- and sham-
operated rats. These factors could be considered to represent different
traits of the emotional response that relate to anxiety- and depression-
like behaviour. The ﬁnal number of surviving operated rats in the two
experimental groups could be considered to be relatively low for a
behavioural study (i.e. six Gsx and 10 sham-operated) and with
reduced statistical power it could therefore be difﬁcult to show
signiﬁcant differences between the groups. However, it seems clear
that the two experimental groups have a different emotional response.
From further consideration of the ﬁrst emotionality factor⁄trait it is
possible to deduce that spatial orientation and exploration of new
surroundings are probably impaired in Gsx rats, as reﬂected in
particular by the number of rearings in the peripheral area and the
number of line crossings in the open ﬁeld test. As rearing has been
shown to involve central monoaminergic systems (Hofele et al., 2001)
we explored the turnover of dopamine (DOPAC⁄DA) and serotonin
(5-HIAA⁄5-HT) in the nucleus accumbens and found that both were
suppressed in Gsx rats. Given the role of the nucleus accumbens in the
brain’s reward system together with data describing the role of the
stomach-derived hormone ghrelin in targeting the midbrain dopamine
system (Jerlhag et al., 2007) it is perhaps more likely that dopamine
inputs from the ventral tegmental area as well as serotonergic
projections from the dorsal raphe nucleus regulate accumbal mono-
amine turnover.
The most important variable within the second emotionality
factor⁄trait of the multivariate analysis was time spent immobile in
the forced swim test. Immobility is interpreted as an indicator of
behavioural despair (Porsolt et al., 1977; Cryan et al., 2002) and in
the Gsx rats time spent in this posture was decreased, indicating an
anti-depressive effect of Gsx. This conclusion should, however, be
made with some caution as we cannot rule out the possibility that
differences in body weight between the two groups could have
inﬂuenced the outcome of the forced swim test due to differences in
buoyancy. In the open ﬁeld and the black and white box there were
trends in both tests for a decreased number of groomings in Gsx rats.
As grooming behaviour and stress are closely linked this trend may be
the effect of the reduced levels of corticosterone. Finally, the results of
the forced swim test are not in accordance with the clinical situation in
which ‘depression’ is described as part of an altered psychiatric proﬁle
in Gsx patients (Fujita et al., 2003), for which there may be
Table 5. Comparison of cerebral serotonin (5-HT), 5-hydroxiindolacetic acid (5-HIAA), turnover of serotonin (TU 5-HT), dopamine, (DA), dihydroxyphenylacetic
acid (DOPAC), homovanillic acid (HVA) and turnover of dopamine (DOPAC ⁄ DA and HVA ⁄ DA) expressed in fmol ⁄ g of tissue between sham-operated (n = 10)
and Gsx rats (n =6 )
Prefrontal cortex Nucleus accumbens
Sham Gsx Sham Gsx
5-HT 619.83 ± 29.28 686.26 ± 44.97 946.35 ± 36.69 948.06 ± 33.25
5-HIAA 229.29 ± 12.19 211.80 ± 7.94 314.22 ± 14.01 281.02 ± 15.04
5-HIAA ⁄ 5HT 0.37 ± 0.02 0.312 ± 0.02 0.33 ± 0.01 0.29 ± 0.01*
DA 402.73 ± 63.23 755.10 ± 313.03 3730.15 ± 160.49 3645.32 ± 551.23
DOPAC 357.18 ± 18.25 450.16 ± 71.89 913.07 ± 45.19 618.88 ± 167.26
HVA 47.52 ± 4.25 50.04 ± 14.31 155.45 ± 13.93 125.64 ± 18.81
DOPAC ⁄ DA 1.08 ± 0.21 0.91 ± 0.20 0.24 ± 0.01 0.15 ± 0.03*
HVA ⁄ DA 0.12 ± 0.02 0.08 ± 0.01 0.04 ± 0.00 0.04 ± 0.00
Values are expressed as mean ± SEM. *P < 0.05.
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Fig. 5. Effects of Gsx on hippocampal mRNA expression of adipor1
(adiponectin receptor 1), insulin receptor (insr), Egr-1 (early growth response
protein 1), Trh (thyrotropin-releasing hormone) and Galr3 (galanin receptor 3)
in comparison with sham-operation. P < 0.05 for all comparisons.
1692 N. Salome ´ et al.
ª 2011 The Authors. European Journal of Neuroscience ª 2011 Federation of European Neuroscience Societies and Blackwell Publishing Ltd
European Journal of Neuroscience, 33, 1685–1695confounding factors and alternative explanations (e.g. post-cancer
trauma and side-effects associated with malnutrition and dumping
syndrome; Liedman, 1999).
The mechanism underpinning the effects of Gsx on emotional
reactivity probably involves altered gut–brain endocrine signalling and
also endocrine disturbances that are secondary to weight loss. Gsx is
associated with suppressed levels of ghrelin, obestatin, gastrin,
pancreastatin and leptin and with an increase in meal-associated
CCK release (Inoue et al., 1987; Dornonville de la Cour et al., 2005;
Furnes et al., 2008b). Several of the hormones affected by Gsx have
been shown previously to be associated with emotional responses
when administered centrally. Intracerebroventricular injection of
ghrelin has been shown to increase anxiety-like behaviour in a dose-
dependent manner in rodents (Carlini et al., 2002) whereas reduced
central ghrelin signalling using antisense DNA for ghrelin causes an
antidepressant and anxiolytic response in rats (Kanehisa et al., 2006).
Another study reported, surprisingly, beneﬁcial effects of ghrelin to
defend against depressive-like symptoms of chronic stress (Lutter
et al., 2008). Given that ghrelin levels are suppressed by Gsx, a
chronic intervention, our recent study showing effects of chronic
central ghrelin treatment increase anxiety-like behavior is especially
relevant (Hansson et al., 2011).
Increased anxiety-like behaviour has also been reported following
central administration of obestatin (Carlini et al., 2007). CCK is also
considered anxiogenic and the effect of centrally administered CCK
is mediated through the CCK-2 receptor (for a review see Wang
et al., 2005). Given that leptin is anxiolytic when administered
centrally (Liu et al., 2010), suppressed leptin in Gsx rats (Furnes
et al., 2008a) could also contribute to the altered emotional response.
Of course, many of these hormones are also produced centrally,
and so it remains of relevance whether they form an important
afferent gut–brain signal for the control of mood in normal
physiology. Our observation that there is a different emotional
response between the two groups in the tests used to evaluate
anxiety and depression further strengthens the evidence that gut
peptides are involved in emotional processing. Although further
experiments are required to demonstrate that these hormones mediate
the altered emotionality following Gsx, the Gsx model provides
insight regarding the possible consequences of depletion of these
hormones on mood, thereby complementing studies of central
hormone injection.
Gastrectomy causes a memory deﬁcit in rats
Gsx rats also spent less time exploring new objects in the object
recognition test. This suggests a deﬁcit in recognition memory,
speciﬁcally working memory. However, the test is based on the
spontaneous tendency of rats to explore a novel object over a familiar
one and there are therefore alternative explanations that include
decreased motivation to explore new objects or ‘novelty-seeking
behaviour’. It is likely that the reduced gut peptide levels also cause
this effect as gut peptides also play a role in memory function (Carlini
et al., 2008; Lo et al., 2008) and in controlling hippocampal spine
synapse density (Diano et al., 2006). To study if the effects of Gsx on
memory were caused by a decreased adult neurogenesis in the
hippocampus, BrdU labelling as well as gene expression targeting
nerve growth genes were performed. In the BrdU experiments no
difference in the amount of proliferating cells or the number of
neurons was observed between the surgical groups. In addition, we
saw no changes in mRNA expression levels of the neural growth-
associated genes studied, i.e. BDNF, NCAM 1, Ngfb or TrkB.
Gastrectomy alters expression of genes implicated in emotional
reactivity and memory⁄cognition in the hippocampus and
amygdala of rats
Most changes in gene expression were observed in the hippocampus,
in receptor genes associated with gut hormones or nutritional status
but also involved in signal transduction. Hippocampal insulin receptor
expression was down-regulated in Gsx rats. Insulin is important for
cognition and hippocampal insulin receptor expression is increased in
spatial memory training tasks (Zhao et al., 1999) and insulin’s
enhancement of memory seems to be speciﬁc to the hippocampus
(McNay, 2007). Insulin further inﬂuences central production of
galanin (Tang et al., 1997), a peptide described to have anxiolytic
effects (Rajarao et al., 2007). Interestingly, gene expression of the
Galr2 receptor associated with the anti-depressant effects of galanin
was unaltered in Gsx rats whereas Galr3 was distinctly up-regulated.
The reduction in circulating ghrelin levels was not mirrored by a
change in expression of its receptor (GHS-R1A), although it remains
to be determined whether ghrelin effects on neuroplasticity are
mediated via GHS-R1A only or whether they involve signalling via as
yet unidentiﬁed receptors, including receptors for des-octanoyl ghrelin
(Thompson et al., 2004; Muccioli et al., 2007). Ghrelin may also
exert its effect through other routes, such as modulation of insulin
sensitivity (Barazzoni et al., 2008).
The Gsx rats also had a decreased expression of Egr-1 in both
hippocampus and amygdala. Egr-1, also known as Krox-24, zif268,
NGFI-A, ZENK and Tis8, encodes a zink ﬁnger transcription factor
and plays a key role in cell proliferation and is the most widely studied
in the ﬁelds of neural plasticity and cognition. Egr-1-deﬁcient mice are
unable to form long-term memories and have impaired long-term
potentiation (Jones et al., 2001) whereas cognitive enhancement is
associated with an increase of Egr-1 expression in the hippocampus
(Shirvalkar et al., 2006). It should be noted that Egr-1 is up-regulated
following chronic treatment with a variety of anti-depressant drugs
(Bjartmar et al., 2000). Although many neurotransmitter systems are
known to induce the expression of Egr-1, the signalling pathways are
not yet fully identiﬁed. Gene expression of Trh, an important
neuropeptide associated with cognitive functions, was also decreased
in the hippocampus of Gsx rats. Trh mimetics have been shown to
improve memory function (Olson et al., 1995) and interestingly pro-
Trh mRNA levels are increased in the anterior hippocampus in rats
trained in the Morris water maze paradigm (Aguilar-Valles et al.,
2007). Adiponectin, a hormone produced peripherally by adipocytes,
is known to be increased by gastric surgery (Yang et al., 2001).
Adipor1 has been shown to act in the hypothalamus to activate
elements of the insulin and leptin signalling pathways (Coope et al.,
2008). Adipor1 was down-regulated in the hippocampus of Gsx rats,
possibly to compensate for the increased adiponectin levels. Even
though there are no clear studies regarding adiponectin and cognition,
leptin, also derived from fat tissue, has been shown to be involved in
memory processing (Farr et al., 2006). We can only speculate on the
role of altered adiponectin levels due to weight loss, the hippocampal
down-regulation of Adipor1 and importance for loss of memory
function in Gsx rats.
Conclusions
Gsx in rats leads to an altered emotional reactivity together with a
memory deﬁcit that is in line with the clinical observations in Gsx
patients. These behaviour effects may be explained, at least in part, by
reduced dopamine and serotonin turnover in the nucleus accumbens.
The effects on cognition may be explained by changes in gene
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in the hippocampus. Taken together with the emerging neurobiology
of the importance of gut–brain signalling in emotional and cognitive
processes, it seems likely that the endocrine function of the stomach
plays an important role in the altered emotional and cognitive
responses.
Acknowledgements
This research was funded from the European Community’s Seventh Framework
Programme (FP7 ⁄ 2007-2013 under grant agreement no. 245009 and FP7-
HEALTH-2009-241592), the Swedish Medical Research Council (2006-5663,
2009-5266), Novo Nordisk Fonden (GeA ⁄ AIR), ALF Go ¨teborg (SU7601) and
the Swedish Foundation for Strategic Research to the Sahlgrenska Center for
Cardiovascular and Metabolic Research (A305-188). None of these grant-
awarding bodies had a role in study design, in the collection, analysis and
interpretation of the data, in the writing of the report or in the decision to submit
the paper for publication. We also acknowledge Stephanie Romero for
assistance with the neurogenesis experiments.
Abbreviations
5-HIAA, 5-hydroxyindoleacetic acid; 5-HT, 5-hydroxytryptophan (serotonin);
Adipor1, adiponectin receptor 1; BDNF, brain-derived neurotrophic factor;
BrdU, 5-bromo-2-deoxyuridine; DA, dopamine; DOPAC, 3,4-dihydroxyphe-
nylacetic acid; Egr-1, early growth response protein 1; GABA1,3,4, gamm-
abutyric acid receptors 1,3,4; GAD 1, glutamate decarboxylase 1; Gal3, galanin
receptor 3; Gsx, gastrectomy; Htr1a, 2c, serotonin receptor 1a, 2c; HVA,
3-methoxy-4-hydroxyphenyl acetic acid; Insr, insulin receptor; Ncam1, neural
cell adhesion molecule 1; NeuN, neuronal nuclei; Ngfb, nerve growth factor
beta; Ntrk2, neurotrophic tyrosine kinase, receptor, type 2; Prox-1, prospero
homeobox protein 1; Th, tyrosine hydroxylase; Trh, thyrotropin-releasing
hormone.
References
Aguilar-Valles, A., Sanchez, E., de Gortari, P., Garcia-Vazquez, A.I., Ramirez-
Amaya, V., Bermudez-Rattoni, F. & Joseph-Bravo, P. (2007) The expression
of TRH, its receptors and degrading enzyme is differentially modulated in
the rat limbic system during training in the Morris water maze. Neurochem.
Int., 50, 404–417.
Ariyasu, H., Takaya, K., Tagami, T., Ogawa, Y., Hosoda, K., Akamizu, T.,
Suda, M., Koh, T., Natsui, K., Toyooka, S., Shirakami, G., Usui, T.,
Shimatsu, A., Doi, K., Hosoda, H., Kojima, M., Kangawa, K. & Nakao, K.
(2001) Stomach is a major source of circulating ghrelin, and feeding state
determines plasma ghrelin-like immunoreactivity levels in humans. J. Clin.
Endocrinol. Metab., 86, 4753–4758.
Asakawa, A., Inui, A., Kaga, T., Yuzuriha, H., Nagata, T., Fujimiya, M.,
Katsuura, G., Makino, S., Fujino, M.A. & Kasuga, M. (2001) A role of
ghrelin in neuroendocrine and behavioral responses to stress in mice.
Neuroendocrinology, 74, 143–147.
Barazzoni, R., Zanetti, M., Stulle, M., Mucci, M.P., Pirulli, A., Dore, F.,
Panzetta, G., Vasile, A., Biolo, G. & Guarnieri, G. (2008) Higher total
ghrelin levels are associated with higher insulin-mediated glucose disposal in
non-diabetic maintenance hemodialysis patients. Clin. Nutr., 27, 142–149.
Bjartmar, L., Johansson, I.M., Marcusson, J., Ross, S.B., Seckl, J.R. & Olsson,
T. (2000) Selective effects on NGFI-A, MR, GR and NGFI-B hippocampal
mRNA expression after chronic treatment with different subclasses of
antidepressants in the rat. Psychopharmacology (Berl), 151, 7–12.
Campbell, S. & Macqueen, G. (2004) The role of the hippocampus in the
pathophysiology of major depression. J. Psychiatry Neurosci., 29, 417–426.
Carlini, V.P., Monzon, M.E., Varas, M.M., Cragnolini, A.B., Schioth, H.B.,
Scimonelli, T.N. & de Barioglio, S.R. (2002) Ghrelin increases anxiety-like
behavior and memory retention in rats. Biochem. Biophys. Res. Commun.,
299, 739–743.
Carlini, V.P., Schioth, H.B. & Debarioglio, S.R. (2007) Obestatin improves
memory performance and causes anxiolytic effects in rats. Biochem. Biophys.
Res. Commun., 352, 907–912.
Carlini, V.P., Martini, A.C., Schioth, H.B., Ruiz, R.D., Fiol de Cuneo, M. & de
Barioglio, S.R. (2008) Decreased memory for novel object recognition in
chronically food-restricted mice is reversed by acute ghrelin administration.
Neuroscience, 153, 929–934.
Coope, A., Milanski, M., Araujo, E.P., Tambascia, M., Saad, M.J., Geloneze, B.
& Velloso, L.A. (2008) AdipoR1 mediates the anorexigenic and insu-
lin ⁄ leptin-like actions of adiponectin in the hypothalamus. FEBS Lett., 582,
1471–1476.
Cryan, J.F., Markou, A. & Lucki, I. (2002) Assessing antidepressant activity in
rodents: recent developments and future needs. Trends Pharmacol. Sci., 23,
238–245.
Diano, S., Farr, S.A., Benoit, S.C., McNay, E.C., da Silva, I., Horvath, B.,
Gaskin, F.S., Nonaka, N., Jaeger, L.B., Banks, W.A., Morley, J.E., Pinto, S.,
Sherwin, R.S., Xu, L., Yamada, K.A., Sleeman, M.W., Tschop, M.H. &
Horvath, T.L. (2006) Ghrelin controls hippocampal spine synapse density
and memory performance. Nat. Neurosci., 9, 381–388.
Dornonville de la Cour, C., Bjorkqvist, M., Sandvik, A.K., Bakke, I., Zhao,
C.M., Chen, D. & Hakanson, R. (2001) A-like cells in the rat stomach
contain ghrelin and do not operate under gastrin control. Regul. Pept., 99,
141–150.
Dornonville de la Cour, C., Lindqvist, A., Egecioglu, E., Tung, Y.C., Surve, V.,
Ohlsson, C., Jansson, J.O., Erlanson-Albertsson, C., Dickson, S.L. &
Hakanson, R. (2005) Ghrelin treatment reverses the reduction in weight gain
and body fat in gastrectomised mice. Gut, 54, 907–913.
Egecioglu, E., Stenstrom, B., Pinnock, S.B., Tung, L.Y.C., de la Cour, C.D.,
Lindqvist, A., Hakanson, R., Syversen, U., Chen, D. & Dickson, S.L. (2008)
Hypothalamic gene expression following ghrelin therapy to gastrectomized
rodents. Regul. Pept., 146, 176–182.
Everitt, N.J., Noble, T.W., Hosie, K.B. & Rogers, K. (1995) Psychiatric
consequences of radical curative surgery for gastric cancer. J. R. Soc. Med.,
88, 516–517.
Farr, S.A., Banks, W.A. & Morley, J.E. (2006) Effects of leptin on memory
processing. Peptides, 27, 1420–1425.
Fujita, T., Nagayama, A. & Anazawa, S. (2003) Circulating alpha-2-macro-
globulin levels and depression scores in patients who underwent abdominal
cancer surgery. J. Surg. Res., 114, 90–94.
Furnes, M.W., Stenstrom, B., Tommeras, K., Skoglund, T., Dickson, S.L.,
Kulseng,B.,Zhao,C.M.&Chen,D.(2008a)Feedingbehaviorinratssubjected
to gastrectomy or gastric bypass surgery. Eur. Surg. Res., 40, 279–288.
Furnes, M.W., Tommeras, K., Arum, C.J., Zhao, C.M. & Chen, D. (2008b)
Gastric bypass surgery causes body weight loss without reducing food intake
in rats. Obes. Surg., 18, 415–422.
Gorsuch, E.L., Grinshpun, S.A., Willeke, K., Reponen, T., Moss, C.E. &
Jensen, P.A. (1998) Method for evaluating germicidal ultraviolet inactivation
of biocontaminated surfaces. Int. J. Occup. Saf. Ergon., 4, 287–297.
Hansson, C., Haage, D., Taube, M., Egecioglu, E., Salome ´, N. & Dickson, S.
(2011) Central administration of ghrelin alters emotional responses in rats:
behavioural, electrophysiological and molecular evidence. Neuroscience,
doi: 10.1016/j.neuroscience.2011.02.002 [Epub ahead of print].
Hebb, A.L., Poulin, J.F., Roach, S.P., Zacharko, R.M. & Drolet, G. (2005)
Cholecystokinin and endogenous opioid peptides: interactive inﬂuence on
pain, cognition, and emotion. Prog. Neuropsychopharmacol. Biol. Psychi-
atry, 29, 1225–1238.
Hernandez-Gomez, A.M., Aguilar-Roblero, R. & Perez de la Mora, M. (2002)
Role of cholecystokinin-A and cholecystokinin-B receptors in anxiety.
Amino Acids., 23, 283–290.
Hjermstad, M.J., Hollender, A., Warloe, T., Karlsen, K.O., Ikonomo, I., Kvaloy,
S., Nome, O. & Holte, H. (2006) Quality of life after total or partial
gastrectomy for primary gastric lymphoma. Acta Oncol., 45, 202–209.
Hofele, K., Sedelis, M., Auburger, G.W., Morgan, S., Huston, J.P. &
Schwarting, R.K. (2001) Evidence for a dissociation between MPTP toxicity
and tyrosinase activity based on congenic mouse strain susceptibility. Exp.
Neurol., 168, 116–122.
Inoue, K., Fuchigami, A., Hosotani, R., Kogire, M., Huang, Y.S., Miyashita, T.,
Suzuki, T., Tsuda, K., Seino, Y., Rayford, P.L., Thompson., J.C. & Tobe, T.
(1987) Release of cholecystokinin and gallbladder contraction before and
after gastrectomy. Ann. Surg., 205, 27–32.
Jerlhag, E., Egecioglu, E., Dickson, S.L., Douhan, A., Svensson, L. & Engel,
J.A. (2007) Ghrelin administration into tegmental areas stimulates locomotor
activity and increases extracellular concentration of dopamine in the nucleus
accumbens. Addict. Biol., 12, 6–16.
Jones, M.W., Errington, M.L., French, P.J., Fine, A., Bliss, T.V., Garel, S.,
Charnay, P., Bozon, B., Laroche, S. & Davis, S. (2001) A requirement for the
immediate early gene Zif268 in the expression of late LTP and long-term
memories. Nat. Neurosci., 4, 289–296.
Kanehisa, M., Akiyoshi, J., Kitaichi, T., Matsushita, H., Tanaka, E., Kodama,
K., Hanada, H. & Isogawa, K. (2006) Administration of antisense DNA for
1694 N. Salome ´ et al.
ª 2011 The Authors. European Journal of Neuroscience ª 2011 Federation of European Neuroscience Societies and Blackwell Publishing Ltd
European Journal of Neuroscience, 33, 1685–1695ghrelin causes an antidepressant and anxiolytic response in rats. Prog.
NeuroPsychopharmacol., 30, 1403–1407.
Liedman, B. (1999) Symptoms after total gastrectomy on food intake, body
composition, bone metabolism, and quality of life in gastric cancer patients –
Is reconstruction with a reservoir worthwhile. Nutrition, 15, 677–682.
Liu, J., Garza, J.C., Bronner, J., Kim, C.S., Zhang, W. & Lu, X.Y. (2010) Acute
administration of leptin produces anxiolytic-like effects: a comparison with
ﬂuoxetine. Psychopharmacology, 207, 535–545.
Livak, K.J. & Schmittgen, T.D. (2001) Analysis of relative gene expression
data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method.
Methods, 25, 402–408.
Lo, C.M., Samuelson, L.C., Chambers, J.B., King, A., Heiman, J., Jandacek,
R.J., Sakai, R.R., Benoit, S.C., Raybould, H.E., Woods, S.C. & Tso, P.
(2008) Characterization of mice lacking the gene for cholecystokinin. Am. J.
Physiol. Regul. Integr. Comp. Physiol., 294, R803–R810.
Lutter, M., Sakata, I., Osborne-Lawrence, S., Rovinsky, S.A., Anderson, J.G.,
Jung, S., Birnbaum, S., Yanagisawa, M., Elmquist, J.K., Nestler, E.J. &
Zigman, J.M. (2008) The orexigenic hormone ghrelin defends against
depressive symptoms of chronic stress. Nat. Neurosci., 11, 752–753.
Mathew, S.J., Price, R.B. & Charney, D.S. (2008) Recent advances in the
neurobiology of anxiety disorders: implications for novel therapeutics. Am. J.
Med. Genet. C, Semin. Med. Genet., 148C, 89–98.
McNay, E.C. (2007) Insulin and ghrelin: peripheral hormones modulating
memory and hippocampal function. Curr. Opin. Pharmacol., 7, 628–632.
Muccioli, G., Baragli, A., Granata, R., Papotti, M. & Ghigo, E. (2007)
Heterogeneity of ghrelin ⁄ growth hormone secretagogue receptors. Toward
the understanding of the molecular identity of novel ghrelin ⁄ GHS receptors.
Neuroendocrinology, 86, 147–164.
Olson, G.L., Cheung, H.C., Chiang, E., Madison, V.S., Sepinwall, J., Vincent,
G.P., Winokur, A. & Gary, K.A. (1995) Peptide mimetics of thyrotropin-
releasing hormone based on a cyclohexane framework: design, synthesis,
and cognition-enhancing properties. J. Med. Chem., 38, 2866–2879.
Porsolt, R.D., Le Pichon, M. & Jalfre, M. (1977) Depression: a new animal
model sensitive to antidepressant treatments. Nature, 266, 730–732.
Rajarao, S.J., Platt, B., Sukoff, S.J., Lin, Q., Bender, C.N., Nieuwenhuijsen,
B.W., Ring, R.H., Schechter, L.E., Rosenzweig-Lipson, S. & Beyer, C.E.
(2007) Anxiolytic-like activity of the non-selective galanin receptor agonist,
galnon. Neuropeptides, 41, 307–320.
Ramos, A. & Mormede, P. (1998) Stress and emotionality: a multidimensional
and genetic approach. Neurosci. Biobehav. Rev., 22, 33–57.
Shirvalkar, P., Seth, M., Schiff, N.D. & Herrera, D.G. (2006) Cognitive
enhancement with central thalamic electrical stimulation. Proc. Natl. Acad.
Sci. USA, 103, 17007–17012.
Tang, C., Akabayashi, A., Manitiu, A. & Leibowitz, S.F. (1997) Hypothalamic
galanin gene expression and peptide levels in relation to circulating insulin:
possible role in energy balance. Neuroendocrinology, 65, 265–275.
Thompson, N.M., Gill, D.A., Davies, R., Loveridge, N., Houston, P.A.,
Robinson, I.C. & Wells, T. (2004) Ghrelin and des-octanoyl ghrelin promote
adipogenesis directly in vivo by a mechanism independent of the type 1a
growth hormone secretagogue receptor. Endocrinology, 145, 234–242.
Wang, H., Wong, P.T., Spiess, J. & Zhu, Y.Z. (2005) Cholecystokinin-2
(CCK2) receptor-mediated anxiety-like behaviors in rats. Neurosci. Biobe-
hav. Rev., 29, 1361–1373.
Wu, C.W., Lo, S.S., Shen, K.H., Hsieh, M.C., Lui, W.Y. & P’Eng F, K. (2000)
Surgical mortality, survival, and quality of life after resection for gastric
cancer in the elderly. World J. Surg., 24, 465–472.
Yang, W.S., Lee, W.J., Funahashi, T., Tanaka, S., Matsuzawa, Y., Chao, C.L.,
Chen, C.L., Tai, T.Y. & Chuang, L.M. (2001) Weight reduction increases
plasma levels of an adipose-derived anti-inﬂammatory protein, adiponectin.
J. Clin. Endocrinol. Metab., 86, 3815–3819.
Zhao, W., Chen, H., Xu, H., Moore, E., Meiri, N., Quon, M.J. & Alkon, D.L.
(1999) Brain insulin receptors and spatial memory. Correlated changes in
gene expression, tyrosine phosphorylation, and signaling molecules in the
hippocampus of water maze trained rats. J. Biol. Chem., 274, 34893–34902.
Gastrectomy alters emotional reactivity in rodents 1695
ª 2011 The Authors. European Journal of Neuroscience ª 2011 Federation of European Neuroscience Societies and Blackwell Publishing Ltd
European Journal of Neuroscience, 33, 1685–1695